Biotech startups that raised a seed round in California, United States
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Welltory | Redwood City | Seed | $2.0M | 2026-10-08 |
| PGxAI | Palo Alto | Seed | $3.0M | 2026-09-14 |
| Rybodyn | San Diego | Seed | $1.3M | 2026-07-23 |
| Kopra Bio | San Francisco | Seed | $9.1M | 2026-06-16 |
| ParcelBio | San Francisco | Seed | $13.0M | 2026-05-07 |
| Fermeate | San Francisco | Seed | $2.5M | 2026-04-27 |
| TippingPoint Biosciences | San Francisco | Seed | $4.5M | 2026-03-31 |
| Avenue Biosciences | Palo Alto | Seed | $7.4M | 2026-01-12 |
8 rows of the CSV in 5 of its 18 columns.
- The 561 biotech startups in California, United States whose last round is a seed round have raised $2.6B in total.
- 91 of them closed their most recent round in the last 12 months, $857.4M combined.
- The largest of those rounds is Merge Labs' $252.0M seed round, dated January 2026.
- The most recent is Omabit's $2.0M seed round on 26 October 2026.
- Y Combinator is an investor in 23 of them, more than any other fund.
- Health care is the most common other sector, with 417 companies (74%).
- 43% were founded in 2020 or later; the median founding year is 2018.
- The most common team size is 1 to 10 employees (66% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
25 of 561| Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| Welltory | Welltory produces AI-powered wellness apps for digital health tracking. | Artificial intelligence | Redwood City | Seed | $2.0M | 2026-10-08 | $16.3M | Goodwater Capital, JOINT JOURNEY, CABRA VC | 51 to 100 | 2016 |
| PGxAI | PGxAI provides a clinical decision support platform for pharmacogenomics, medication safety, and real-world evidence. | Artificial intelligence | Palo Alto | Seed | $3.0M | 2026-09-14 | $5.0M | ATEM Capital Fund LP | 11 to 50 | 2023 |
| Rybodyn | Rybodyn develops therapeutics that train the immune system to detect and eradicate cancer. | Biotech | San Diego | Seed | $1.3M | 2026-07-23 | $15.3M | SOSV, SOSV SF & NY (Fka IndieBio) | 11 to 50 | 2022 |
| Kopra Bio | Kopra Bio develops viral immunotherapy treatments to cure cancer. | Biotech | San Francisco | Seed | $9.1M | 2026-06-16 | $9.7M | Y Combinator, Pioneer Fund | 1 to 10 | 2024 |
| ParcelBio | ParcelBio develops RNA medicine delivery systems and therapeutic development platforms. | Biotech | San Francisco | Seed | $13.0M | 2026-05-07 | $13.5M | Y Combinator, Alumni Ventures, Pioneer Fund +2 | 1 to 10 | 2024 |
| Fermeate | Fermeate provides photomolecular fermentation technology that makes biomanufacturing more sustainable and efficient. | Biotech | San Francisco | Seed | $2.5M | 2026-04-27 | $2.5M | SOSV, SOSV SF & NY (Fka IndieBio) | 1 to 10 | 2024 |
| TippingPoint Biosciences | TippingPoint Biosciences develops therapeutics that target genome packaging states in diseases such as cancer. | Biotech | San Francisco | Seed | $4.5M | 2026-03-31 | $4.5M | SOSV, SOSV SF & NY (Fka IndieBio) | 1 to 10 | 2022 |
| Avenue Biosciences | Avenue Biosciences is a transatlantic biotech company specializing in protein engineering technologies. | Biotech | Palo Alto | Seed | $7.4M | 2026-01-12 | $9.9M | Inventure, Voima Ventures | 11 to 50 | 2023 |
| Ligo Biosciences | Ligo Biosciences develops deep-learning models for enzyme design to lower the cost of chemical manufacturing. | Biotech | San Francisco | Seed | $500K | 2026-01-01 | $500K | Y Combinator | 1 to 10 | 2024 |
| 1849 Bio | 1849 Bio creates microbes that extract metals affordably from low-grade copper and gold ores. | Biotech | San Francisco | Seed | $500K | 2026-01-01 | $500K | Y Combinator | 1 to 10 | 2024 |
| Olio Labs | Olio Labs uses AI to develop combination therapeutics that minimize side effects by discovering protein interactions. | Artificial intelligence | California City | Seed | $4.5M | 2025-03-19 | $8.7M | Y Combinator, Pioneer Fund, Unpopular Ventures +1 | 1 to 10 | 2023 |
| BioSapien | BioSapien is a biotech startup that provides a drug delivery platform for cancer treatment. | Biotech | San Diego | Seed | $8.0M | 2024-12-13 | $45.1M | SOSV, National Science Foundation, SOSV SF & NY (Fka IndieBio) +2 | 1 to 10 | 2018 |
| Valora Therapeutics | Valora Therapeutics engineers chimeric antibodies as a biotechnology company. | Biotech | La Jolla | Seed | $30.0M | 2024-11-20 | $30.0M | Correlation Ventures, Alexandria Venture Investments, TigerGene +2 | 11 to 50 | 2023 |
| Switch Bioworks | Switch Bioworks produces sustainable nitrogen fertilizer using reprogrammed symbiotic microbes. | Biotech | San Carlos | Seed | $17.0M | 2024-09-05 | $25.1M | Astanor Ventures, Acre Venture Partners, Thia Ventures | 11 to 50 | 2022 |
| Catena Biosciences | Catena Biosciences provides protein conjugation, biologic structure building, and medical research services. | Biotech | Berkeley | Seed | $2.4M | 2024-05-10 | $8.1M | Y Combinator, Pioneer Fund, Caffeinated Capital +2 | 1 to 10 | 2020 |
| NEXT Life Sciences | NEXT Life Sciences develops the Plan A procedure, a scientifically studied technology in its category. | Biotech | San Luis Obispo | Seed | $2.5M | 2024-01-16 | $4.0M | StartUp Health, Seaside Ventures, Particular Ventures | 11 to 50 | 2021 |
| Sway | Sway develops compostable plastic alternatives made from seaweed. | Biotech | Oakland | Seed | $5.0M | 2023-12-05 | $8.1M | Trousdale Ventures, Climate Capital, Centre Street Partners +1 | 11 to 50 | 2020 |
| Flashpoint Therapeutics | Flashpoint Therapeutics develops a new approach to building cancer immunotherapies. | Biotech | Redwood City | Seed | $10.0M | 2023-10-25 | $10.0M | Beta Lab, CS Venture Opportunities Fund | 1 to 10 | 2022 |
| Sonera Magnetics | Sonera Magnetics develops non-invasive, high-performance brain-computer interface technology. | Biotech | Berkeley | Seed | $11.0M | 2023-09-12 | $11.2M | National Science Foundation, Abstract, Spark Capital +2 | 1 to 10 | 2018 |
| Persephone Biosciences | Persephone Biosciences uses artificial intelligence to develop microbial-based immunotherapies for cancer. | Artificial intelligence | San Diego | Seed | $15.0M | 2022-07-19 | $15.1M | Y Combinator, Pioneer Fund, ZhenFund +2 | 11 to 50 | 2017 |
| Narrativa | Narrativa offers a generative AI software platform that automates content creation and business processes. | Artificial intelligence | Santa Monica | Seed | $533K | 2022-06-01 | $2.4M | F6 Ventures | 11 to 50 | 2015 |
| Genomelink | Genomelink lets people explore their DNA data and helps businesses use it for building products, marketing, and research. | Biotech | Berkeley | Seed | $3.5M | 2021-07-01 | $8.1M | Y Combinator, 500 Global, Liquid 2 Ventures +2 | 11 to 50 | 2017 |
| Atexto | Atexto provides voice data solutions that enable voice interfaces as alternatives to keyboards. | Artificial intelligence | San Francisco | Seed | $713K | 2019-12-02 | $1.1M | 500 Global, Start-Up Chile, Redwood Capital Partners +2 | 10,001 or more | 2018 |
| Evid Science | Evid Science uses AI to analyze the primary medical literature and build a therapy evidence database. | Artificial intelligence | El Segundo | Seed | $150K | 2019-03-20 | $650K | Wavemaker 360 | 1 to 10 | 2017 |
| Genome Compiler | Genome Compiler develops computer-aided design and collaboration software for synthetic biology. | Biotech | Los Altos | Seed | $5.8M | 2015-06-09 | $5.8M | NFX, LionBird, Techammer +1 | 11 to 50 | 2011 |
Table 1. Biotech startups that raised a seed round in California, United States: the 25 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 561.
Largest rounds
Last 12 months| # | Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ParcelBio | ParcelBio develops RNA medicine delivery systems and therapeutic development platforms. | Biotech | San Francisco | Seed | $13.0M | 2026-05-07 | $13.5M | Y Combinator, Alumni Ventures, Pioneer Fund +2 | 1 to 10 | 2024 |
| 2 | Kopra Bio | Kopra Bio develops viral immunotherapy treatments to cure cancer. | Biotech | San Francisco | Seed | $9.1M | 2026-06-16 | $9.7M | Y Combinator, Pioneer Fund | 1 to 10 | 2024 |
| 3 | Avenue Biosciences | Avenue Biosciences is a transatlantic biotech company specializing in protein engineering technologies. | Biotech | Palo Alto | Seed | $7.4M | 2026-01-12 | $9.9M | Inventure, Voima Ventures | 11 to 50 | 2023 |
| 4 | TippingPoint Biosciences | TippingPoint Biosciences develops therapeutics that target genome packaging states in diseases such as cancer. | Biotech | San Francisco | Seed | $4.5M | 2026-03-31 | $4.5M | SOSV, SOSV SF & NY (Fka IndieBio) | 1 to 10 | 2022 |
| 5 | PGxAI | PGxAI provides a clinical decision support platform for pharmacogenomics, medication safety, and real-world evidence. | Artificial intelligence | Palo Alto | Seed | $3.0M | 2026-09-14 | $5.0M | ATEM Capital Fund LP | 11 to 50 | 2023 |
| 6 | Fermeate | Fermeate provides photomolecular fermentation technology that makes biomanufacturing more sustainable and efficient. | Biotech | San Francisco | Seed | $2.5M | 2026-04-27 | $2.5M | SOSV, SOSV SF & NY (Fka IndieBio) | 1 to 10 | 2024 |
| 7 | Welltory | Welltory produces AI-powered wellness apps for digital health tracking. | Artificial intelligence | Redwood City | Seed | $2.0M | 2026-10-08 | $16.3M | Goodwater Capital, JOINT JOURNEY, CABRA VC | 51 to 100 | 2016 |
| 8 | Rybodyn | Rybodyn develops therapeutics that train the immune system to detect and eradicate cancer. | Biotech | San Diego | Seed | $1.3M | 2026-07-23 | $15.3M | SOSV, SOSV SF & NY (Fka IndieBio) | 11 to 50 | 2022 |
| 9 | Ligo Biosciences | Ligo Biosciences develops deep-learning models for enzyme design to lower the cost of chemical manufacturing. | Biotech | San Francisco | Seed | $500K | 2026-01-01 | $500K | Y Combinator | 1 to 10 | 2024 |
| 10 | 1849 Bio | 1849 Bio creates microbes that extract metals affordably from low-grade copper and gold ores. | Biotech | San Francisco | Seed | $500K | 2026-01-01 | $500K | Y Combinator | 1 to 10 | 2024 |
Table 2. Biotech startups that raised a seed round in California, United States: the 10 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Y Combinator | Startup accelerator | Mountain View, United States | 23 | 4% | 5 | Kopra Bio, ParcelBio, Ligo Biosciences |
| 2 | SOSV | Venture capital firm | Princeton, United States | 9 | 2% | 4 | Farm Minerals, Rybodyn, Fermeate |
| 3 | Pioneer Fund | Startup accelerator | Toronto, Canada | 8 | 1% | 3 | Kopra Bio, ParcelBio, Angstrom AI |
| 4 | SOSV SF & NY (Fka IndieBio) | Venture capital firm | San Francisco, United States | 7 | 1% | 4 | Farm Minerals, Rybodyn, Fermeate |
| 5 | Alumni Ventures | Angel group | Manchester, United States | 4 | 1% | 1 | ParcelBio |
| 6 | Plug and Play | Startup accelerator | Sunnyvale, United States | 4 | 1% | 1 | WittGen Biotechnologies |
| 7 | 500 Global | Startup accelerator | Palo Alto, United States | 4 | 1% | ||
| 8 | ZAKA VC | Family office | Prague, Czech Republic | 3 | 1% | 1 | ParcelBio |
| 9 | Unpopular Ventures | Syndicate | San Francisco, United States | 3 | 1% | ||
| 10 | National Science Foundation | Entrepreneurship program | Alexandria, United States | 3 | 1% | ||
| 11 | Ulu Ventures | Micro VC fund | Palo Alto, United States | 3 | 1% | ||
| 12 | SeedFolio | Venture capital firm | San Diego, United States | 3 | 1% | ||
| 13 | StartUp Health | Venture capital firm | New York, United States | 3 | 1% | ||
| 14 | Alchemist Accelerator | Startup accelerator | San Francisco, United States | 3 | 1% | ||
| 15 | TCA Venture Group | Angel group | Newport Beach, United States | 3 | 1% |
Table 3. Biotech startups that raised a seed round in California, United States: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Health care | 417 | 74% | $1.7B |
| Software | 123 | 22% | $1.0B |
| Artificial intelligence | 84 | 15% | $546.9M |
| Hardware | 21 | 4% | $236.7M |
| Energy | 7 | 1% | |
| Cybersecurity | 6 | 1% | $22.6M |
| Education | 5 | 1% | $3.3M |
| Fintech | 5 | 1% | $12.5M |
| Commerce | 3 | 1% | $11.1M |
Table 4. Biotech startups that raised a seed round in California, United States by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Seed | 561 | 100% | $2.0M |
Table 5. Biotech startups that raised a seed round in California, United States by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Cities
| Cities | Companies | Share |
|---|---|---|
| San Francisco | 172 | 31% |
| San Diego | 64 | 11% |
| Palo Alto | 30 | 5% |
| Los Angeles | 30 | 5% |
| Berkeley | 27 | 5% |
| San Carlos | 14 | 2% |
| South San Francisco | 14 | 2% |
| San Jose | 11 | 2% |
| Redwood City | 9 | 2% |
| Menlo Park | 9 | 2% |
| Irvine | 9 | 2% |
| Mountain View | 9 | 2% |
Table 6. Biotech startups that raised a seed round in California, United States by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| October 2026 | 13 | 14% | $42.2M |
| September 2026 | 8 | 9% | $58.2M |
| August 2026 | 3 | 3% | $4.0M |
| July 2026 | 7 | 8% | $22.4M |
| June 2026 | 5 | 5% | $59.2M |
| May 2026 | 9 | 10% | $44.1M |
| April 2026 | 5 | 5% | $12.0M |
| March 2026 | 7 | 8% | $178.6M |
| February 2026 | 3 | 3% | $26.6M |
| January 2026 | 20 | 22% | $271.4M |
| December 2025 | 8 | 9% | $109.6M |
| November 2025 | 3 | 3% | $29.0M |
Table 7. Biotech startups that raised a seed round in California, United States: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 80 | 14% | $718.8M |
| 2025 | 62 | 11% | $424.1M |
| 2024 | 52 | 9% | $195.0M |
| 2023 | 39 | 7% | $100.5M |
| 2022 | 42 | 7% | $103.6M |
| 2021 | 55 | 10% | $125.6M |
Table 8. Biotech startups that raised a seed round in California, United States by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 125 | 23% |
| 2020 to 2022 | 111 | 20% |
| 2015 to 2019 | 191 | 35% |
| 2010 to 2014 | 82 | 15% |
| Before 2010 | 42 | 8% |
Table 9. Biotech startups that raised a seed round in California, United States by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 354 | 66% |
| 11 to 50 | 168 | 31% |
| 51 to 100 | 9 | 2% |
| 101 to 250 | 4 | 1% |
| 251 to 500 | 3 | 1% |
| 501 to 1,000 | 1 | 0% |
| 10,001 or more | 1 | 0% |
Table 10. Biotech startups that raised a seed round in California, United States by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Biotech is one of its sectors and its most recent funding round is a seed round and its headquarters is in California, United States. On 16 November 2026 that is 561 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 25 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 561 rows: 204 have no round amount, 0 no city and 112 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many biotech startups in California, United States whose last round is a seed round are on the list?
- 561, in the file dated 16 November 2026. 91 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 561 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $349.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.